Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis-Reference-Cited by-同舟云学术

Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis

Published:2005-01-13 Issue:2 Volume:115 Page:369-378
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Contri Antonella,Brunati Anna Maria,Trentin Livio,Cabrelle Anna,Miorin Marta,Cesaro Luca,Pinna Lorenzo A.,Zambello Renato,Semenzato Gianpietro,Donella-Deana Arianna

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference54 articles.

1. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

2. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

3. B cells and their fate in health and disease

4. Chronic lymphocytic leukaemia: the nature of the leukaemic cell

5. Clinical Effects of Alemtuzumab (Campath-1H) in B-cell Chronic Lymphocytic Leukemia

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies;Science China Life Sciences;2024-08-12

2. Targeting the tumor microenvironment for treating double-refractory chronic lymphocytic leukemia;Blood;2024-08-08

3. CD38/NAD+ glycohydrolase and associated antigens in chronic lymphocytic leukaemia: From interconnected signalling pathways to therapeutic strategies;Biochimie;2024-07

4. Multiple omics levels of chronic lymphocytic leukemia;Cell Death Discovery;2024-06-21

5. PIM kinase inhibitors: an updated patent review (2016-present);Expert Opinion on Therapeutic Patents;2024-05-03